This federal contract award is for a pharmaceutical prime vendor agreement between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,840.24, covers the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
The contract is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive suite of pharmaceutical and medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract does not have a set-aside designation, indicating open competition.
Amerisourcebergen is the prime contractor, and its parent company is Cencora, Inc., which also does business as Amerisourcebergen. The DLA, a defense agency, is the funding agency for this contract, which supports the healthcare needs of military personnel, veterans, and other federal beneficiaries.